Posted by Michael Wonder on 23 Jan 2025
Scilex announces that the US FDA has acknowledged the submission of our supplemental new drug application for Elyxyb in acute pain indication
22 January 2025 - Scilex today announced that the US FDA has acknowledged the submission of our supplemental new drug application for Elyxyb in acute pain indication.
